Albert Selva-O'Callaghan, MD, PhD
Affiliations: | Internal Medicine | Vall d'Hebron Institut de Recerca |
Google:
"Albert Selva-O'Callaghan"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Muñoz-Braceras S, Pinal-Fernandez I, Casal-Dominguez M, et al. (2023) Identification of Unique microRNA Profiles in Different Types of Idiopathic Inflammatory Myopathy. Cells. 12 |
Guerra NL, Matas-García A, Serra-García L, et al. (2023) Dermatomyositis unleashed by immune checkpoint inhibitors. Three additional cases and a review of the literature. Autoimmunity Reviews. 22: 103375 |
Pinal-Fernandez I, Milisenda JC, Pak K, et al. (2023) Transcriptional derepression of CHD4/NuRD-regulated genes in the muscle of patients with dermatomyositis and anti-Mi2 autoantibodies. Annals of the Rheumatic Diseases |
Pinal-Fernandez I, Quintana A, Milisenda JC, et al. (2023) Transcriptomic profiling reveals distinct subsets of immune checkpoint inhibitor induced myositis. Annals of the Rheumatic Diseases |
Casal-Dominguez M, Pinal-Fernandez I, Pak K, et al. (2023) Coordinated local RNA overexpression of complement induced by interferon gamma in myositis. Scientific Reports. 13: 2038 |
Selva-O'Callaghan A, Trallero-Araguás E, Ros J, et al. (2022) Management of Cancer-Associated Myositis. Current Treatment Options in Rheumatology. 8: 91-104 |
Hosono Y, Sie B, Pinal-Fernandez I, et al. (2022) Coexisting autoantibodies against transcription factor Sp4 are associated with decreased cancer risk in patients with dermatomyositis with anti-TIF1γ autoantibodies. Annals of the Rheumatic Diseases |
Zanframundo G, Faghihi-Kashani S, Scirè CA, et al. (2022) Defining anti-synthetase syndrome: a systematic literature review. Clinical and Experimental Rheumatology. 40: 309-319 |
Trallero-Araguás E, Gil-Vila A, Martínez-Gómez X, et al. (2021) Cancer screening in idiopathic inflammatory myopathies: Ten years experience from a single center. Seminars in Arthritis and Rheumatism. 53: 151940 |
Casal-Dominguez M, Pinal-Fernandez I, Pak K, et al. (2021) Performance of the 2017 EULAR/ACR classification criteria for inflammatory myopathies in patients with myositis-specific autoantibodies. Arthritis & Rheumatology (Hoboken, N.J.) |